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Saudi Journal of Ophthalmology (2012) 26, 401–407Oculoplastic Imaging UpdateNeuroimaging in ophthalmologyJames D. Kim, MD, MS b; Nafiseh Hashemi, MD a; Rachel Gelman, BA c; Andrew G. Lee, MD a,b,c,d,e,⇑AbstractIn the past three decades, there have been countless advances in imaging modalities that have revolutionized evaluation, manage-
ment, and treatment of neuro-ophthalmic disorders. Non-invasive approaches for early detection and monitoring of treatments
have decreased morbidity and mortality. Understanding of basic methods of imaging techniques and choice of imaging modalities
in cases encountered in neuro-ophthalmology clinic is critical for proper evaluation of patients. Two main imaging modalities that
are often used are computed tomography (CT) and magnetic resonance imaging (MRI). However, variations of these modalities
and appropriate location of imaging must be considered in each clinical scenario. In this article, we review and summarize the best
neuroimaging studies for specific neuro-ophthalmic indications and the diagnostic radiographic findings for important clinical
entities.
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Advances in neuroimaging have revolutionized the evalua-
tion, management, and treatment of neuro-ophthalmic disor-
ders. Despite the ever-increasing resolution ability of modern
neuroimaging technology, it remains critical that both the
ordering eye physician and the interpreting radiologist com-
municate about the relevant topographical and localizing
anatomy, the clinical and radiographic differential diagnosis,
and the most likely, single best unifying diagnosis (i.e., ‘‘clin-
ical correlation required’’). In this paper, we review and
summarize the best neuroimaging studies for specific neu-
ro-ophthalmic indications and the diagnostic radiographic
findings for important clinical entities.Peer review under responsibility
of Saudi Ophthalmological Society,
King Saud University
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The computed tomography (CT) scan obtains image by
conventional X-ray technology. The CT X-ray source moves
around the patient and the X-ray detectors located on the
opposite side of the X-ray source measure the amount of
attenuation. Data points analyzed by a computer and attenu-
ation values, in Hounsfield units, are assigned to each pixel,
which are then compared to the attenuation value of water
(zero) and reconstructed into an array of pixels forming images
that we see on the computer screen. By convention, denser
materials, such as bone, are displayed bright white, while less
dense material, such as air, is displayed darker. Materials with
densities between these values are displayed in a gray scaleProduction and hosting by Elsevier
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402 J.D. Kim et al.gradient. Iodinated contrast material can be used to improve
the sensitivity and specificity of CT scan interpretation in many
situations. However, in some situations, contrast material
does not add any benefit (e.g., thyroid eye disease), dimin-
ishes the ability to detect the lesion of interest (e.g., acute
hemorrhage), or might be contraindicated (e.g., iodine
allergy).Magnetic resonance imaging
In contrast to CT scan, which uses conventional X-ray tech-
nology, the imaging technique in magnetic resonance imag-
ing (MRI) relies on the interaction of hydrogen atoms, mostly
water, with the intense magnetic field generated by the MRI
scanner. Thus, as opposed to CT, there is no radiation expo-
sure with MRI. Certain atoms become polarized when sub-
jected to a strong magnetic field, creating a net magnetic
vector that is longitudinal to the direction of the magnetic
field. Atoms that are misaligned to the magnetic field can
be forced to align when they absorb a characteristic fre-
quency (Larmor frequency) that is directly proportional to
the strength of the magnetic field that is subjected. This en-
ergy is called excitation and it is re-emitted over time as the
excited atoms move from the higher to the lower energy
state. This process and energy release is known as relaxation.
The basic MRI sequences are T1 and T2 modes. Detailed
discussion of the complex physics and the technical parame-
ters of these methods are beyond the scope of this article,
but a short and simple description of T1 and T2 might be
of value to the ophthalmologist. On a T2 weighted scan,
water and fluid containing tissues are bright and fat-contain-
ing tissues are dark, and on T1-weighted images, the fluid is
dark and the fat is bright. Thus, the T2-weighted imaging is
useful in detecting pathologic tissues that tend to develop
edema and fluid that can be distinguished from normal tis-
sue. However, the ‘‘brightness’’ of normal structures on T1-
and T2-weighted imaging can make it more difficult to detect
pathology. In a specialized T2-weighted sequence, fluid
attenuated inversion recovery (FLAIR), the free water signal
(e.g., in cerebrospinal fluid) can be attenuated and made
dark, while water in edematous and pathologic tissue will re-
main bright. This is particularly useful in demyelinating dis-
ease such as multiple sclerosis, which we discuss later in
this article. Likewise, in T1-weighted imaging, the normal
fat signal is bright and can obscure both pathologic bright
T1 signal and also gadolinium contrast enhancement of
pathology in the fat-filled orbit. Thus, T1 post-contrast stud-
ies with fat suppression sequence of the orbits might be nec-
essary to visualize orbital pathology (e.g., optic nerve sheath
meningioma, intraorbital optic neuritis). In addition to fat-
suppressed T1 and T2 FLAIR, additional special sequences
might be of interest to the ophthalmologist such as diffusion
weighted imaging (DWI) and apparent diffusion coefficient
(ADC). Diffusion weighted MRI measures aberrancies in
expected Brownian motion of free water. A frequent applica-
tion for DWI/ADC is in acute ischemic strokes where in-
creased restriction of water diffusion can differentiate acute
ischemic cytotoxic edema from vasogenic edema. DWI/
ADC imaging can show abnormalities within minutes of the
onset of stroke symptoms (even before structural CT and
conventional MRI show abnormalities) and may remain for
up to two weeks. In MRI, gadolinium, as opposed to theiodinated contrast material of CT, is the contrast material.
As in CT, however, the administration of gadolinium contrast
material increases the sensitivity and specificity of imaging
for neuro-ophthalmology and, in general, contrast material
should be given for most clinical indications.
With this background information in mind, we will now dis-
cuss some specific clinical indications of interest to the oph-
thalmologist for which neuroimaging might be necessary.
Unilateral or bilateral optic neuropathy
In a patient with an unexplained unilateral or bilateral op-
tic neuropathy (e.g., optic atrophy), a pre- and post-contrast
magnetic resonance imaging (MRI) of the head and orbit
might disclose a compressive, inflammatory, or infiltrative eti-
ology. As noted above, fat has a very high signal intensity on
the conventional T1-weighted MRI and suppression of the
fat signal (i.e., fat suppression or fat saturation) is highly
recommended for showing intraorbital lesions, especially
any enhancing optic nerve (e.g., optic neuritis) or optic nerve
sheath (e.g., sheath meningioma) lesions. Imaging along the
intraorbital (i.e., MRI of orbit) and intracranial (i.e., MRI of
brain) course of the optic nerve is essential to exclude an eti-
ology in the setting of an unexplained optic neuropathy.
Optic neuritis
Acute demyelinating optic neuritis (ON) is a common
consideration of acute to subacute painful (pain with eye
movement) unilateral vision loss in young adults. Our recom-
mended imaging modality to exclude demyelinating disease
in ON is MRI with pre- and post-contrast fat suppression of
the orbits to look for enhancement of the optic nerve
(Fig. 1) and T2-weighted brain imaging for periventricular
demyelinating lesions (including sagittal views of the corpus
callosum). As noted above, cerebrospinal fluid (CSF) shows
very high signal intensity on T2-weighted MRI and Fluid
Attenuation Inversion Recovery (FLAIR) sequences can sup-
press the normal CSF bright signal on T2 and allow easier
detection of demyelinating white matter lesions in ON.1,2 In
the Optic Neuritis Treatment Trial (ONTT) patients with ON
without demyelinating lesions in the brain have a 22% risk
of multiple sclerosis (MS) versus a 78% risk of MS after
15 years with multiple white matter lesions.3 Thus, the MRI
is prognostic (but not definitive) for the prediction of future
MS in patients with ON.
Bitemporal hemianopsia
Bitemporal hemianopsia most commonly occurs as a result
of lesions of the optic chiasm. Although compressive lesions
are typical causes for a bitemporal hemianopsia, uncom-
monly, demyelinating (i.e., chiasmal neuritis) and inflamma-
tory (e.g., sarcoid) lesions can occur and might demonstrate
enlargement or enhancement in the chiasm on neuroimag-
ing. Common tumors causing compression of the optic chi-
asm include pituitary adenoma, craniopharyngioma,
meningioma, or dysgerminoma in adults and optic pathway
glioma in children. In addition, internal carotid artery aneu-
rysm can also present with sellar symptoms and signs. MRI
of the sella with and without contrast can help to differentiate
between these pathologies4 (Fig. 2). In the acute setting, CT
Figure 1. Axial (A) and coronal (B) views of T1 sequence post contrast fat suppression magnetic resonance imaging demonstrating post contrast
enhancement of the left optic nerve (arrows).
Figure 2. MRI of the sella in coronal image of post contrast T1 sequence
shows pituitary macroadenoma compressing chiasm from below (arrow).
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tary apoplexy) and CT might also be useful for demonstrating
calcification in a suprasellar lesion or hyperostosis of bone in
meningioma.Homonymous hemianopsia (or cortical blindness)
Any type of intracranial lesion of the retrochiasmal visual
pathways (i.e., lesions of the optic tract, the lateral geniculate
nucleus, the optic radiations, and the occipital cortex) can
cause a homonymous hemianopia. The preferred imaging
study for homonymous hemianopsia is a cranial MRI with
and without contrast with attention to the contralateral retro-
chiasmal pathway. Patients who present acutely (e.g., possi-
ble stroke) or who have high suspicion for intracranial
hemorrhage (e.g., hemorrhagic stroke, pituitary apoplexy,
ruptured aneurysm or arteriovenous malformation) might un-
dergo an initial head CT scan without contrast. In general,
however, even if the initial CT is negative, a follow up MRI
is recommended for acute or chronic ischemic lesions pro-
ducing a homonymous hemianopsia. Diffusion weighted
imaging (DWI) is a special MR imaging technique that is very
helpful to differentiate the various phases of cerebral infarc-
tion (e.g., hyperacute, acute, subacute or chronic) and, inconjunction with apparent diffusion coefficient technique
(ADC), can demonstrate restricted diffusion consistent with
ischemia. In the acute setting DWI and ADC MRI sequences
can discriminate reversible vasogenic edema (bright signal
on T2 and FLAIR, but no restricted diffusion on DWI/ADC),
as seen in posterior reversible encephalopathy syndrome
(PRES), from less reversible cytotoxic edema in ischemic
stroke (bright signal on T2 and FLAIR with restricted diffusion
on DWI/ADC). In vasogenic edema the diffusion of water
molecules is increased, so the ADC is elevated and the DWI
shows iso- or hypo-intense signal. In contrast, in cytotoxic
edema the movement of water from the extracellular to the
intracellular compartment produces restricted diffusion, so
the ADC is decreased and the DWI appears hyperintense5–
10 (Fig. 3). The clinical importance for the ophthalmologist
is that DWI/ADC imaging of homonymous hemianopsia or
cortical blindness in patients with PRES may be prognostic
for recovery (i.e., the deficit is reversible), whereas ischemic
infarction with restricted DWI/ADC might not recover.Cranial nerve palsy
Ocular motor cranial neuropathies (e.g., third, fourth, or
sixth nerve palsy) typically are best imaged with cranial pre-
and post-contrast MRI following the course of the involved
nerve(s). Newer MRI sequences, such as CISS (constructive
interference in steady-state) and FIESTA (fast imaging
employing steady-state acquisition), have been deployed to
better demonstrate the cranial nerves and might be particu-
larly useful for smaller intrinsic lesions of the nerve (e.g., ocu-
lomotor nerve schwannoma).11 The sixth cranial nerve runs
along the clivus to either side of the midline and CT scan,
in conjunction with cranial MRI, might show any lesion involv-
ing bone or sinus disease better (Fig. 4).
Although typically MRI is the superior imaging strategy for
ocular motor cranial neuropathy, when a patient presents
with an acute third nerve palsy (especially with pupil involve-
ment) the most emergent diagnosis is a posterior communi-
cating artery aneurysm. Patients may present with ptosis,
anisocoria, diplopia and headache. Severe headache (e.g.,
‘‘worst headache of my life’’), nausea, and/or vomiting might
indicate a ruptured aneurysm with subarachnoid hemor-
rhage. In this setting, the initial imaging modality of choice
Figure 3. (A) Hyperintensity in DWI due to acute infarct in the left MCA distribution caused right homonymous hemianopsia (arrow). (B) Hypointensity in
ADC due to acute infarct of left MCA distribution (arrow).
Figure 4. MRI of brain (sagittal, T1, post contrast) shows a clival
chondroma (arrow) in a 29 year-old patient with a left 6th nerve palsy.
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for subarachnoid hemorrhage followed by a contrast com-
puted tomography angiogram (CTA) for aneurysm. In many
institutions, CTA offers faster and better results than MRA
for detection of aneurysm, but the ordering clinician should
discuss the pros and cons of each study with their institutional
neuroradiologist in advance to design the best imaging strat-
egy for third nerve palsy.
Nystagmus
Nystagmus is a rhythmic oscillating movement of the
eyes.12 Brainstem imaging, typically with cranial MRI, is the
best initial study for any unexplained nystagmus. Although
most forms of nystagmus require brainstem imaging, a few
types of nystagmus localize to other specific locations. For
example, see-saw nystagmus may be seen in lesions that in-
volve the midbrain or parasellar region (e.g., pituitary tumor
or craniopharyngioma)13 and spasmus nutans in children
might be associated with an optic pathway glioma. Down-
beat nystagmus and periodic alternating nystagmus may beseen in disorders affecting the cervicomedullary junction14
(e.g., Arnold-Chiari malformation15, skull base tumors, spi-
nocerebellar degenerations16 and toxic metabolic syn-
dromes).17 Convergence retraction nystagmus may be seen
in the setting of the dorsal midbrain syndrome.18 Oculopala-
tal myoclonus is a pendular vertical nystagmus associated
with compromised pathway between the inferior olive, den-
tate nucleus of the cerebellum, and red nucleus due to olivary
hypertrophy following stroke, multiple sclerosis, or head trau-
ma.19,20 Thus, in general, pre- and post-contrast cranial MRI is
the imaging study of choice for unexplained nystagmus.Proptosis
Proptosis is a condition where the globe abnormally pro-
trudes anteriorly. The most common cause of unilateral or
bilateral proptosis in adults is thyroid ophthalmopathy.
Computed tomography (CT) and MRI of the orbit, without
contrast, are both neuroimaging studies that can be used to
make the diagnosis of thyroid eye disease (TED) (Fig. 5). Con-
trast is typically not necessary however because of the intrin-
sic contrast provided by fat in the orbit. In addition, for CT
orbit iodinated contrast material might potentiate iodine-in-
duced thyrotoxicosis. CT is also superior to MRI for evaluat-
ing sinus disease and for bone especially before and after
orbital decompression in TED. Thus, our recommendation
for TED is CT rather than MRI of the orbit. Other causes for
proptosis include: orbital cellulitis, orbital inflammatory dis-
ease (e.g., idiopathic, Wegener granulomatosis, systemic lu-
pus erythematosus) and neoplasm (e.g., meningioma,
glioma, hemangioma21, lymphangioma22, metastasis, or lym-
phoma23). In children unilateral proptosis is commonly due to
orbital cellulitis24 and subperiosteal abcess6, and in bilateral
cases neuroblastoma25 and leukemia26 are the most likely
causes. CT scan of the orbit is recommended for the initial
evaluation of acute onset proptosis (Fig. 6A). CT is faster than
an MRI and can be useful for defining orbital cellulitis, orbital
abscess, idiopathic orbital inflammation, thyroid orbitopathy
with compressive optic neuropathy or vision threatening
Figure 5. A 30 year old female with thyroid eye disease status post left orbital wall decompression. The T1 weighted MRI sequence of coronal (A) and
axial (B) views show markedly enlarged extraocular muscles.
Figure 6. A 20 year old male with allergic fungal sinusitis with severe expansion of the ethmoid sinus pressing on the medial rectus and pushing the
orbital content anteriorly. The CT scan (A) shows great details of the bony structure, while the T1sequence MRI with fat suppression (B) shows the great
details of the soft tissue in orbit and sinus.
Figure 7. A 46 year old white male presenting with left ptosis and
anisocoria from left Horner’s syndrome. Patient had left carotid artery
dissection. T1 weighted sequence with contrast in axial view shows classic
‘‘crescent sign’’ (arrow) in distal portion of the left internal carotid artery.
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hemorrhage.27 For more chronic lesions, orbital fat-sup-
pressed post-contrast MRI (Fig. 6B) may be required to ob-
tain more detailed imaging of the lesion of interest.
Horner’s syndrome
A Horner syndrome (HS) is characterized clinically by ipsi-
lateral ptosis and miosis with anisocoria greater in the dark.
HS can be divided into three types, depending on where
the disruption lies along the oculosympathetic pathway: cen-
tral, preganglionic and postganglionic.28
Central causes of HS are typically recognized based on
the accompanying neurologic signs and symptoms that indi-
cate involvement of the hypothalamus, brainstem or cervico-
thoracic spinal cord (e.g., ataxia, diplopia, hemisensory or
hemimotor loss). Most commonly, central HS is of vascular
etiology leading to lateral medullary syndrome, but other
causes include tumors, trauma, demyelination, and arterio-
venous malformations. MRI of the head and neck to the sec-
ond thoracic vertebra (T2) with and without gadolinium is
probably the single best mode of imaging for HS. In the
acute setting, a painful HS is commonly caused by internal
carotid artery (ICA) dissection (Fig. 7). A T1-weighted MRI
of the neck with contrast and fat suppression, in additionto MR angiography (MRA) of the neck, might be diagnostic.
The diagnostic MRI sign is a crescent of hyperintense signal
Table 1. Neuro-ophthalmologic indications and recommended imaging study. (modified from Lee et al27 with permission).
Clinical indication Preferred imaging study Contrast material Comment
Bilateral optic disc swelling Magnetic resonance imaging (MRI)
head with magnetic resonance
venogram (MRV) Computed
tomography (CT) scan might be first
line study in emergent setting.
Yes Consider concomitant contrast MRV to
exclude venous sinus thrombosis,
especially in atypical cases of
pseudotumor cerebri who are thin,
male, or elderly.
Transient monocular visual loss
(amaurosis fugax) due to ischemia
Magnetic resonance angiogram
(MRA) or computed tomography
angiogram (CTA) of neck for carotid
stenosis or dissection.
Depends on clinical
situation
Carotid Doppler study might be first
line and may still require follow up
catheter angiography.
Demyelinating optic neuritis MRI head and orbit Yes (enhancing lesions
suggest acute disease)
Fluid attenuated inversion recovery
(FLAIR) to look for demyelinating white
matter lesions. MRI has prognostic
significance for development of
multiple sclerosis.
Inflammatory, infiltrative, or
compressive optic neuropathy
MRI head and orbit Yes Fat suppression to exclude intraorbital
optic nerve enhancement CT is
superior in traumatic optic neuropathy
for canal fractures.
Bitemporal hemianopsia MRI head (attention to chiasm and
sella)
Yes Consider CT of sella if an emergent
scan is needed (e.g. pituitary or
chiasmal apoplexy) or if imaging for
calcification (e.g., meningioma or
craniopharyngioma or aneurysm).
Homonymous hemianopsia MRI head Yes Retrochiasmal pathway. Diffusion
weighted imaging (DWI) may be useful
if acute ischemic infarct or Posterior
reversible encephalopathy syndrome
(PRES). If structural imaging negative
and organic loss consider functional
imaging like positron emission
tomography (PET)
Cortical visual loss or visual
association cortex (e.g., cerebral
achromatopsia, alexia,
prosopagnosia, simultagnosia,
optic ataxia, Balint’s syndrome)
MRI head Yes Retrochiasmal pathway. Consider DWI
in ischemic infarct. If structural imaging
negative and organic loss consider
functional imaging (e.g., PET, Single
photon emission computed
tomography (SPECT), or MRI
spectroscopy (MRS)).
Third, fourth, sixth nerve palsy or
cavernous sinus syndrome.
MRI head with attention to the skull
base. Isolated vasculopathic cranial
neuropathies may not require initial
imaging.
Yes Rim calcification in aneurysm,
calcification in tumors, and
hyperostosis may be better seen on
CT.
Nystagmus MRI brainstem Yes Localize nystagmus.
Horner syndrome: preganglionic MRI head and neck to second thoracic
vertebra (T2) in chest with neck MRA
Yes Rule out lateral medullary infarct,
brachial plexus injury, apical lung
neoplasm, carotid dissection, etc.
Horner syndrome: post-ganglionic MRI head and neck to level of
superior cervical ganglion (C4 level)
with MRA neck
Yes Rule out carotid dissection. Isolated
post-ganglionic lesions are often
benign.
Thyroid eye disease CT or MRI of orbit Iodinated contrast may
interfere with
evaluation and
treatment of systemic
thyroid disease.
Bone anatomy is better seen on a CT
scan especially if orbital
decompression is being considered.
Orbital cellulitis and orbital disease
secondary to sinus disease
CT orbit and sinuses Depends on clinical
situation
MRI and/or CT with CTA may be useful
adjunct to a CT alone; especially if
possible concomitant cavernous sinus
thrombosis is present.
Orbital tumor (e.g., proptosis or
enophthalmos, gaze-evoked visual
loss)
CT or MRI of orbit Yes Include head imaging if lesion could
extend intracranially. MRI with contrast
is superior at determining intracranial
extent of primary optic nerve tumors
(e.g., optic nerve glioma or sheath
meningioma). CT scan may be superior
if looking for hyperostosis or
calcification.
406 J.D. Kim et al.intensity on T1 surrounding the typically hypointense normal
carotid artery flow void. CT and CTA of the neck might also
be diagnostic for a carotid dissection, has some advantagesover conventional MRI and MRA of the neck, and at some
institutions, may be the initial evaluation of choice in acute
HS.
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Papilledema is optic disc swelling caused by an increased
intracranial pressure. Patients usually present with headache,
blurred vision, or diplopia (from a non-localizing sixth nerve
palsy), or may even be asymptomatic. Although CT scan
might be useful in acute or emergent setting, our definitive
imaging recommendation for papilledema is MRI of the brain
and orbits with and without contrast, with fat suppression of
the orbit, and MRV of the head. The MRI might show an eti-
ology for increased intracranial pressure including meningeal
disease, hydrocephalus, or space-occupying lesions, or may
show radiographic signs of idiopathic intracranial hyperten-
sion (IIH), such as an empty sella, fluid in the optic nerve
sheath and posterior indentation of the globe. The MRV
of the head might show sinus stenosis or venous sinus
thrombosis.
Summary
Ophthalmologists should be aware of the specific clinical
indications for CT and MRI in neuro-ophthalmology and be
prepared to recognize the distinctive radiographic signs for
each clinical entity (Table 1). In general, MRI is superior to
CT scanning for most intracranial neuro-ophthalmic indica-
tions, but CT still has a role in cases of acute hemorrhage,
hydrocephalus, bone pathology, trauma, orbital disease, si-
nus disease, thyroid eye disease and for those patients who
are unable to undergo an MR scan. In addition, in some cen-
ters CTA may be superior to MRA for some vascular condi-
tions (e.g., carotid dissection or arterial aneurysm). In most
cases, contrast material for both CT and MR should be or-
dered for any neuro-ophthalmic indication unless there is a
clear contraindication, but in some cases contrast may not
be necessary (e.g., thyroid eye disease). Special MRI se-
quences of interest to ophthalmology include fat suppres-
sion, fluid-attenuated inversion recovery, and DWI/ADC.
Finally, we cannot emphasize enough the critical importance
for the ordering ophthalmologist to provide the interpreting
radiologist with the pertinent clinical information, including
the differential diagnosis and the suspected location of a le-
sion, to obtain the best neuroradiologic interpretation (i.e.,
‘‘clinical correlation is required’’).
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